It is trading at $375.36 which is marginally higher than $356.38, the 50 day moving average and which is quite a bit higher than the 200 day moving average of $319.86. The 50 day moving average moved up $18.98 whereas the 200 day moving average was up $55.50 or +17.35%. Trading volume for Intuitive Surgical, Inc. was 816K by the end of trading on Tuesday. Volume was down 1.98% under the stocks average daily volume.
Short traders are more bearish on Intuitive Surgical, Inc. of late if you look at the rise in short interest. The company had a rise in short interest from September 29, 2017 to October 13, 2017 of 12.66%. Short interest grew 631,115 over that period. The short-interest ratio decreased to 7.0 and the short interest percentage is 0.05% as of October 13.
There has been some selling insider activity on Intuitive Surgical, Inc. (NASDAQ:ISRG) recently. Director Craig H. Barratt disclosed the sale of 7,500 shares of (ISRG). The shares were purchased at an average price of $381.00. The Director now owns $0 of the stock according to the SEC filing. Lonnie M. Smith, Director let go of $6,707,520 worth of shares at an average price of $372.64 on October 24th. That brings the Director’s holdings to $208,458,542 per an SEC filing yesterday.
Mark J. Rubash, Director reported the sale of 6,750 shares of ISRG stock. The shares were sold on October 24th for an average price of $371.17. Rubash now owns $1,281,650 of the stock per the Form 4 SEC filing.
Here are a few substantial investment firms who have updated their positions. As of the end of the quarter Tokio Marine Asset Management Co Ltd had disposed of 122 shares trimming its position 27.1%. The value of the investment in (ISRG) decreased from $422,000 to $344,000 a change of $78,000 for the reporting period. As of quarter end Edgestream Partners, L.p. had bought a total of 635 shares growing its stake by 126.2%. The value in dollars went from $470,000 to $1,190,000 a change of 153.2% quarter over quarter.
As of the end of the quarter Simplex Trading, LLC had disposed of 2,697 shares trimming its holdings by 64.3%. The value of the company’s investment in Intuitive Surgical, Inc. went from $3,922,000 to $1,564,000 decreasing 60.1% quarter to quarter. Andra Ap-fonden bolstered its holdings by buying 1,489 shares an increase of 7.3% from 06/30/2017 to 09/30/2017. Andra Ap-fonden now controls 21,889 shares with a value of $22,893,000. The value of the position overall is up by 20.0%.
On October 20 Barclays left the stock rating at “Overweight” and lowered the price target from $750.00 to $370.00. October 20 investment analysts at Morgan Stanley kept the stock rating at “Overweight” but moved up the price target to $390.00 from $1.00.
On October 23 Citigroup held the stock rating at “Buy” and moved down the price target to $432.00 from $750.00.
The most current P/E ratio is 53.94 and market cap is 41.83B. In the latest earnings report the EPS was $6.96 and is estimated to be $8.67 for the current year with 111,452,000 shares now outstanding. Next quarter’s EPS is estimated at $1.98 with next year’s EPS anticipated to be $9.35.
Intuitive Surgical, Inc. (Intuitive), launched on November 9, 1995, designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Business’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies..